Unusual presentation of multiple endocrine neoplasia type 2A in a patient with the C634R mutation of the RET-protooncogene

Niccoli-Sire, 2007, Multiple endocrine neoplasia type 2, Ann Endocrinol (Paris), 68, 317, 10.1016/j.ando.2007.04.005

Schuffenecker, 1998, Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe d’étude des études des tumeurs à calcitonine, J Clin Endocrinol Metab, 83, 487

Ayturk, 2006, Changes in insulin sensitivity and glucose and bone metabolism over time in patients with asymptomatic primary hyperparathyroidism, J Clin Endocrinol Metab, 91, 4260, 10.1210/jc.2005-2825

Mollerup, 2002, Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study, BMJ, 325, 785, 10.1136/bmj.325.7368.807

Hagström, 2007, Serum calcium is independently associated with insulin sensitivity measured with euglycaemic-hyperinsulinaemic clamp in a community-based cohort, Diabetologia, 50, 317, 10.1007/s00125-006-0532-9

Procopio, 2002, The oral glucose tolerance test reveals a high frequency of both impaired glucose tolerance and undiagnosed Type 2 diabetes mellitus in primary hyperparathyroidism, Diabet Med, 19, 958, 10.1046/j.1464-5491.2002.00809.x

Jacob, 2008, Primary hyperparathyroidism and chronic pancreatitis, J Gastroenterol Hepatol, 23, 164, 10.1111/j.1440-1746.2007.05233.x

Gursoy, 2006, Severe reversible dilated cardiomyopathy in a patient with multiple endocrine neoplasia 2A syndrome, J Endocrinol Invest, 29, 363, 10.1007/BF03344110

Uehara, 1993, Tumor resection attenuated the impaired tolerance of glucose in patients with asymptomatic pheochromocytoma, J Med, 24, 193

Wiesner, 2003, Improvement of insulin sensitivity after adrenalectomy in patients with pheochromocytoma, J Clin Endocrinol Metab, 88, 3632, 10.1210/jc.2003-030000

Murao, 2007, A case of pheochromocytoma complicated with slowly progressive type 1 diabetes mellitus and chronic thyroiditis, Endocrine, 32, 350, 10.1007/s12020-008-9049-y

Raue, 1995, Primary hyperparathyroidism in multiple endocrine neoplasia type 2A, J Intern Med, 238, 369, 10.1111/j.1365-2796.1995.tb01212.x

Mulligan, 1994, Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC, Nat Genet, 6, 70, 10.1038/ng0194-70

Puñales, 2003, RET codon 634 mutations in multiple endocrine neoplasia type 2: variable clinical features and clinical outcome, J Clin Endocrinol Metab, 88, 2644, 10.1210/jc.2002-021422

Kikumori, 2001, Genetic abnormalities in multiple endocrine neoplasia type 2, 531

Eng, 1996, The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis, JAMA, 276, 1575, 10.1001/jama.1996.03540190047028

Machens, 2005, Codon-specific development of pheochromocytoma in multiple endocrine neoplasia type 2, J Clin Endocrinol Metab, 90, 3999, 10.1210/jc.2005-0064